ALNY vs BHE · P/E 76, rev $1.29B vs P/E 89, rev $1.43B
Alnylam Pharmaceuticals Inc (ALNY) versus Benchmark Electronics Inc (BHE) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Benchmark Electronics Inc (BHE) is a electronic components company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported BHE revenue for 2026-06-30 was $1.43B. Net income was $32.9M. BHE currently screens at market cap $3.01B and trailing P/E 89.3.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. BHE currently screens at market cap $3.01B and trailing P/E 89.3.
Not investment advice. Open the ALNY and BHE stock pages for the full models.
Not investment advice.